Glaukos (GKOS) Net Margin (2014 - 2026)

Glaukos' (GKOS) quarterly Net Margin came in at 13.15% in Q1 2026, up 386.0% year-on-year from 2.71% in Q1 2025, and up 86.46% on a QoQ basis from 97.13% in Q4 2025.

Glaukos (GKOS) Net Margin (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Net Margin data on file, last reported at 13.15% in Q1 2026.

  • On a quarterly basis, Net Margin rose 386.0% year-over-year to 13.15% in Q1 2026; TTM through Mar 2026 was 35.31%, a 475.0% decrease from a year earlier, with the FY2025 full-year figure at 38.04%, up 13.0% from the prior year.
  • Net Margin for Q1 2026 stood at 13.15%, up from 97.13% in the prior quarter.
  • Over the last five years, Net Margin for GKOS reached as high as 7.98% in Q1 2022 and fell as low as 97.13% in Q4 2025.
  • Historically, Net Margin has averaged 36.62% across 5 years, with a median of 39.01% in 2023.
  • On a YoY basis, Net Margin climbed as much as 3695 bps in 2025 and fell as far as 6530 bps in 2025.
  • Year by year, Net Margin stood at 48.22% in 2022, then grew by 7 bps to 44.62% in 2023, then climbed by 29 bps to 31.83% in 2024, then plunged by 205 bps to 97.13% in 2025, then jumped by 86 bps to 13.15% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 13.15% in Q1 2026, 97.13% in Q4 2025, and 12.15% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn -13.15%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.15%
Dec 31, 2025 -97.13%
Sep 30, 2025 -12.15%
Jun 30, 2025 -15.84%
Mar 31, 2025 -17.01%
Dec 31, 2024 -31.83%
Sep 30, 2024 -22.15%
Jun 30, 2024 -52.79%
Mar 31, 2024 -47.70%
Dec 31, 2023 -44.62%
Sep 30, 2023 -39.01%
Jun 30, 2023 -40.81%
Mar 31, 2023 -46.86%
Dec 31, 2022 -48.22%
Sep 30, 2022 -38.63%
Jun 30, 2022 -62.66%
Mar 31, 2022 7.98%
Dec 31, 2021 -29.86%
Sep 30, 2021 8.34%
Jun 30, 2021 -22.39%